Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effects of Vanilla on Hypoxic Intermittent Events in Premature Infants

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Länken sparas på Urklipp
StatusRekrytering
Sponsorer
Université de Sherbrooke

Nyckelord

Abstrakt

The purpose of this study is to evaluate the effect of vanilla odor on hypoxic intermittent events in premature infants born between 32.0 and 33.6 weeks of gestational age.

Beskrivning

A weekly screening will be done on all new hospitalized infants at the neonatal care unit of the CHUS born between 32.0 and 33.6 weeks of gestational age. At the beginning of their 2nd week in the neonatal care unit, infant's medical record will be consult for inclusion and exclusion criteria. At this moment, no information will be noted. Then, team research will discuss with neonatologist to have their opinion concerning the inclusion of a patient in the study. If they agree, the doctor or the nurse having a therapeutic link with the infant will ask parents' infant if they agree to meet the research team to discuss about the research project. Once the agreement will be obtained, parents will be approached by a member of the research team. Project will be explained, questions will be answered and consent form will be obtained. When an infant will be enrolled in the study, a code will be attributed to him and a randomization will established the order of the intervention.

Option A) night 1: a 12h cardiorespiratory recording with vanilla, night 2: no recording and night 3: a 12h cardiorespiratory recording without vanilla OR Option B): night 1: a 12h cardiorespiratory recording without vanilla, night 2: no recording and night 3: a 12h cardiorespiratory recording recording with vanilla.

A 3h polysomnography will be done in a sub-sample of 10-15 infants in the morning by the night 1 and 3 according by the pre-existing condition of vanilla or not.

All data will be entered in a secured database and a double checked will be done by team members to assess the accuracy.

Datum

Senast verifierad: 06/30/2019
Först skickat: 12/03/2015
Beräknad anmälan inlämnad: 12/13/2015
Först publicerad: 12/14/2015
Senaste uppdatering skickad: 07/10/2019
Senaste uppdatering publicerad: 07/14/2019
Faktiskt startdatum för studien: 08/31/2015
Uppskattat primärt slutdatum: 11/30/2019
Beräknat slutfört datum: 05/31/2020

Tillstånd eller sjukdom

Premature Birth
Neonatal Hypoxic Conditions

Intervention / behandling

Other: Night-vanilla

Fas

-

Armgrupper

ÄrmIntervention / behandling
Experimental: Night-vanilla
Intervention = exposition to vanilla scent A quantity of 2 ml of a saturated vanilla solution (2% vanillin) will be applied on premature pyjamas infant's, close to his face (on each shoulder and on the upper chest).
Other: Night-vanilla
A 12-hour continuous recording for monitoring hemoglobin oxygen saturation, electrocardiogram and respiratory movements will be performed while the infant is exposed to vanilla scent (from vanilla solution on the infant's pyjamas). In addition, a 3-hour polysomnography will be done in a sub-sample on the morning following the night recording with vanilla solution.
No Intervention: Night-no vanilla
The only difference with the experimental arm is the absence of vanilla (usual, standard care)

Urvalskriterier

Kön som är berättigade till studierAll
Accepterar friska volontärerJa
Kriterier

Inclusion Criteria:

- Infants born between 32.0 and 33.6 weeks of gestational age;

- Postnatal age between 3 and 4 weeks;

- No current respiratory or ventilatory support;

- Stable state for at least the last 48 hours;

- Parental consent to enroll in the study.

Exclusion Criteria:

- Respiratory diseases other than apnea;

- Intraventricular hemorrhage grade 3 or 4 OR leukomalacia;

- Chromosomal abnormality;

- Congenital malformations which may result in cardiorespiratory or neurodevelopmental abnormality;

- Clinical deterioration during the study.

Resultat

Primära resultatåtgärder

1. Number of hypoxic intermittent events [night 1 and 3]

Number of changes in the number of hypoxic intermittent events

Sekundära resultatåtgärder

1. Duration of oxygen saturation under 80% and under 90% [night 1 and 3]

Change in the duration of oxygen saturation under 80% and under 90%

2. Number of bradycardias [night 1 and 3]

Change in the number of bradycardias

3. Duration of periodic breathing [night 1 and 3]

Change in the duration of periodic breathing

4. Heart rate variability [night 1 and 3]

Change in heart rate variability

5. Respiratory rate variability [night 1 and 3]

Change in respiratory rate variability

Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge